Literature DB >> 25311213

Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.

Lee W Jones1, Qi Liu2, Gregory T Armstrong2, Kirsten K Ness2, Yutaka Yasui2, Katie Devine2, Emily Tonorezos2, Luisa Soares-Miranda2, Charles A Sklar2, Pamela S Douglas2, Leslie L Robison2, Kevin C Oeffinger2.   

Abstract

PURPOSE: Survivors of Hodgkin lymphoma (HL) are at increased risk of treatment-related cardiovascular (CV) events; whether exercise modifies this risk is unknown.
METHODS: Survivors of HL (n = 1,187; median age, 31.2 years) completed a questionnaire evaluating vigorous-intensity exercise behavior. CV events were collected in follow-up questionnaires and graded according to Common Terminology Criteria for Adverse Events (version 4.03). The primary end point was incidence of any major (grade 3 to 5) CV event. Poisson regression analyses were used to estimate the association between exercise exposure (metabolic equivalent [MET] hours/week(-1)) and risk of major CV events after adjustment for clinical covariates and cancer treatment.
RESULTS: Median follow-up was 11.9 years (range, 1.7 to 14.3 years). Cumulative incidence of any CV event was 12.2% at 10 years for survivors reporting 0 MET hours/week(-1) compared with 5.2% for those reporting ≥ 9 MET hours/week(-1). In multivariable analyses, the incidence of any CV event decreased across increasing MET categories (Ptrend = .002). Compared with survivors reporting 0 MET hours/week(-1), the adjusted rate ratio for any CV event was 0.87 (95% CI, 0.56 to 1.34) for 3 to 6 MET hours/week(-1), 0.45 (95% CI, 0.26 to 0.80) for 9 to 12 MET hours/week(-1), and 0.47 (95% CI, 0.23 to 0.95) for 15 to 21 MET hours/week(-1). Adherence to national vigorous intensity exercise guidelines (ie, ≥ 9 MET hours/week(-1)) was associated with a 51% reduction in the risk of any CV event in comparison with not meeting the guidelines (P = .002).
CONCLUSION: Vigorous exercise was associated with a lower risk of CV events in a dose-dependent manner independent of CV risk profile and treatment in survivors of HL.
© 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 25311213      PMCID: PMC4220043          DOI: 10.1200/JCO.2014.56.7511

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  47 in total

1.  Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial.

Authors:  Lee W Jones; Kerry S Courneya; Adrian S Fairey; John R Mackey
Journal:  Ann Behav Med       Date:  2004-10

2.  Reliability and validity of YRBS physical activity items among middle school students.

Authors:  Philip J Troped; Jean L Wiecha; Maren S Fragala; Charles E Matthews; Daniel M Finkelstein; Juhee Kim; Karen E Peterson
Journal:  Med Sci Sports Exerc       Date:  2007-03       Impact factor: 5.411

Review 3.  Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study.

Authors:  Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

Review 4.  Exercise protects the cardiovascular system: effects beyond traditional risk factors.

Authors:  Michael J Joyner; Daniel J Green
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

5.  Cardiotoxicity after childhood cancer: beginning with the end in mind.

Authors:  Steven E Lipshultz; M Jacob Adams
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

6.  Physical activity and coronary heart disease in men: The Harvard Alumni Health Study.

Authors:  H D Sesso; R S Paffenbarger; I M Lee
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

7.  The influence of exercise training on inflammatory cytokines and C-reactive protein.

Authors:  Laura K Stewart; Michael G Flynn; Wayne W Campbell; Bruce A Craig; J Paul Robinson; Kyle L Timmerman; Brian K McFarlin; Paul M Coen; Erin Talbert
Journal:  Med Sci Sports Exerc       Date:  2007-10       Impact factor: 5.411

8.  Exercise training in childhood cancer survivors with subclinical cardiomyopathy who were treated with anthracyclines.

Authors:  Webb A Smith; Kirsten K Ness; Vijaya Joshi; Melissa M Hudson; Leslie L Robison; Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2013-11-06       Impact factor: 3.167

9.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

Authors:  Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  Med Pediatr Oncol       Date:  2002-04

10.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

Authors:  Daniel A Mulrooney; Mark W Yeazel; Toana Kawashima; Ann C Mertens; Pauline Mitby; Marilyn Stovall; Sarah S Donaldson; Daniel M Green; Charles A Sklar; Leslie L Robison; Wendy M Leisenring
Journal:  BMJ       Date:  2009-12-08
View more
  65 in total

1.  Obesity and Metabolic Disease After Childhood Cancer.

Authors:  Dana Barnea; Nirupa Raghunathan; Danielle Novetsky Friedman; Emily S Tonorezos
Journal:  Oncology (Williston Park)       Date:  2015-11       Impact factor: 2.990

Review 2.  Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

Review 3.  Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Authors:  Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-12       Impact factor: 32.069

4.  Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

Authors:  Kasey J Leger; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Wendy M Leisenring; Paul J Martin; Jason A Mendoza; Kerryn W Reding; Karen L Syrjala; Stephanie J Lee; Eric J Chow
Journal:  Cancer       Date:  2018-01-09       Impact factor: 6.860

Review 5.  Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.

Authors:  Monica Samuel Avila; Suellen Rodrigues Rangel Siqueira; Silvia Moreira Ayub Ferreira; Edimar Alcides Bocchi
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

Review 6.  Frailty in childhood cancer survivors.

Authors:  Kirsten K Ness; Gregory T Armstrong; Mondira Kundu; Carmen L Wilson; Tamara Tchkonia; James L Kirkland
Journal:  Cancer       Date:  2014-12-19       Impact factor: 6.860

7.  Factors associated with physical activity among adolescent and young adult survivors of early childhood cancer: A report from the childhood cancer survivor study (CCSS).

Authors:  Katie A Devine; Ann C Mertens; John A Whitton; Carmen L Wilson; Kirsten K Ness; Jordan Gilleland Marchak; Wendy Leisenring; Kevin C Oeffinger; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  Psychooncology       Date:  2017-08-31       Impact factor: 3.894

8.  Are lifestyle behavioral factors associated with health-related quality of life in long-term survivors of non-Hodgkin lymphoma?

Authors:  Denise J Spector; Devon Noonan; Deborah K Mayer; Habtamu Benecha; Sheryl Zimmerman; Sophia K Smith
Journal:  Cancer       Date:  2015-06-02       Impact factor: 6.860

9.  Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity.

Authors:  Fei Wang; Brian Iskra; Eugenie Kleinerman; Claudia Alvarez-Florez; Thomas Andrews; Angela Shaw; Joya Chandra; Keri Schadler; Gregory J Aune
Journal:  J Pediatr Hematol Oncol       Date:  2018-04       Impact factor: 1.289

10.  Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults.

Authors:  Ana C Xavier; Narendranath Epperla; Jeffrey W Taub; Luciano J Costa
Journal:  Am J Hematol       Date:  2017-11-21       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.